Archive for the ‘Treatment’ Category

Revolving Door Strikes Again

https://www.midwesterndoctor.com/p/the-revolving-door-strikes-again?

The Revolving Door Strikes Again

Why did the FDA relentlessly suppress all evidence of vaccine injuries?

Many individuals I’ve spoken to believe Peter Marks is the government official most directly responsible for the entire COVID catastrophe, and those I know who directly interacted with him despise him. For that reason, six months ago, I published a detailed exposé of his conduct throughout the pandemic, both to highlight the systemic issues within our healthcare bureaucracy that must be fixed and to disincentivize other health officials from following in his footsteps. Since that time:

•Despite immense industry pushback, he was replaced with MAHA appointee Vinay Prasad

•Marks has made statements on the national media which display either a profound degree of ignorance of vaccines or a cult-like devotion to them, such as telling CBS the MMR vaccine absolutely does not cause encephalitis—despite this specific injury being one of the only vaccine injuries the Federal Government acknowledged as real and eligible for compensation when it created the the National Childhood Vaccine Injury Act of 1986.

Note: the primary reason DMSO (a safe and affordable substance with remarkable therapeutic applications against a wide range of “incurable” ailments) never entered mainstream medical practice was because the FDA, feeling DMSO’s broad therapeutic potential threatened their control of American medicine, waged a multi-decade war against it despite widespread opposition from the public, Congressmen, scientists and physicians across the country. One journalist who interviewed the successive FDA commissioners throughout this saga was struck by how “lacking [they were] in solid information about the most spectacular and controversial drug of our time” and how often they simply quoted nonsensical misinformation the FDA had previously put out about the drug without a basic understanding of it—something I would argue also applies to Peter Marks.

•Yesterday, it was announced that Peter Marks had started working with Eli Lilly, where he will oversee molecule discovery and infectious diseases at Lilly. While his salary has not been publicly announced, the AI systems I queried said given the existing precedent, he would likely get 2-6 million this year (a big upgrade from his roughly $200,000.00 FDA salary)—and possibly much more (e.g. 10-15 million).

This understandably enraged the vaccine injured parties who directly interacted with Marks over the last four years, so I felt it was important to revisit exactly what Marks did and discuss the broader revolving door in regulatory medicine.

Note: last year, the FDA approved Eli Lilly’s anti-amyloid monoclonal antibody for the treatment of Alzheimer’s disease (granting the application Fast Track, Priority Review, and Breakthrough Therapy designations). I showed in last weekend’s article, that these costly drugs do close to nothing (they may slightly slow the progression of Alzheimer’s disease) while simultaneously creating a variety of severe symptoms including giving over a quarter of recipients brain bleeds and brain swelling—yet remarkably, safer and much more effective Alzhemier’s therapies have languished in obscurity. (See link for article)

______________

**Comment**

I’m with Rodney Dangerfield on TOBAL,

“There Oughta be a law!”

For more:

ACTION: Stop Hemp Ban!

https://anh-usa.org/stop-the-hemp-ban-now/

Stop the Hemp Ban Now!

Stop the Hemp Ban Now!

A dangerous provision has been included in a Congressional spending bill that could spell the end of your access to full-spectrum hemp products. Action Alert!

Listen to the audio version of this article:


THE TOPLINE

  • A provision in the House Agriculture Appropriations Subcommittee’s FY 2026 spending bill would ban all ingestible hemp products containing “quantifiable amounts” of THC or THC-like cannabinoids—effectively outlawing many CBD and full-spectrum hemp oils that contain small, non-psychoactive amounts of THC.
  • While the measure is framed as targeting unregulated, intoxicating products like delta-8, it goes far beyond that by threatening the entire hemp industry and cutting off consumer access to safe, beneficial full-spectrum hemp products.
  • The provision still faces hurdles, including reconciliation with the Senate version of the bill and ongoing political uncertainty, but urgent grassroots opposition is needed to prevent it from becoming law.

If you rely on hemp, CBD, or full-spectrum hemp oil to support your health, listen up!

A dangerous provision buried in a House spending bill threatens to ban most of the hemp products currently available on the market. Just as research continues to confirm the remarkable healing potential of hemp and CBD—showing their impact on the body’s endocannabinoid system, which influences everything from mood to immunity—some in Congress are moving to strip away our access. We must raise strong grassroots opposition to stop this misguided policy.

The House Agriculture Appropriations Subcommittee’s spending bill for FY 2026 contains a deeply troubling provision that effectively bans the production and sale of all hemp-derived products that contain “quantifiable amounts” of THC (one of the psychoactive components of hemp that provides the “high”) or cannabinoids with similar, THC-like effects. What “quantifiable amounts” means specifically is to be determined later by regulators.

Put in plain terms, this would ban all ingestible hemp products with any level of THC in them. This means that many CBD oil and full-spectrum hemp oil products would suddenly become illegal.

The goal of the amendment is to close a loophole created by the previous Farm Bill that has allowed unregulated, intoxicating hemp products on the market. Recall that the 2018 Farm Bill legalized hemp at the federal level, defining it as a cannabis plant with less than 0.3 percent THC. In the six years since that bill became law, some companies found a way to stay within the guardrails put in place by the new law but still be able to chemically synthesize psychoactive or intoxicating products from legal hemp plants. These products include members of the THC family like delta-8 and delta-10. Delta-8 occurs naturally in the hemp plant at miniscule levels, but higher levels of delta-8 THC are produced artificially in the laboratory by chemically converting CBD through a process called isomerization.

While the merits of cracking down on delta-8 and other products can be debated, what’s crystal clear is that this amendment goes far beyond banning delta-8 and similar products and takes a huge swipe at the hemp industry as a whole without any justification.

Some of the best and healthiest products are full-spectrum hemp oils that contain all of the nearly 500 known compounds known to be present in hemp, including cannabinoids (>60), terpenes (>140), and fatty acids that occur naturally in the plant. Among this morass of compounds are tiny, non-psychoactive amounts of THC. The real benefits of hemp come from the “entourage effect” of all these different chemicals acting together. For example, a 2015 study found that highly purified CBD was somewhat effective in treating inflammation and anxiety in mice, but was substantially more effective when the CBD was present in a full spectrum extract because it benefits from the synergy from the full entourage of typically associated compounds.

Banning, in one fell swoop, all hemp products with “quantifiable amounts” of THC is the very definition of throwing the baby out with the bath water and will take vital products out of our medicine cabinets.

Remember, too, that is not the only threat to CBD access. Because CBD has been approved as a drug, the FDA maintains that it cannot be a supplement, though the agency appears only to be going after CBD companies making illegal disease claims. The agency has said that it believes a new regulatory pathway is needed to deal with CBD. Whatever that pathway is, you can bet the agency will do its best to protect drug industry profits by making it next to impossible to have affordable CBD supplements.

There are still a number of hurdles before this can ever become law. Similar language was added to the Senate version of this bill, but Senator Rand Paul (R-KY) was able to remove it. House and Senate versions of the bill would need to be further negotiated and reconciled before being sent to the President for approval. The possibility of a government shutdown in the coming weeks further complicates matters.

There is no time to lose. We must oppose this terrible policy and kill it before the bill moves any further.

Action Alert!

(Go to top link for sign petition)

_______________

**Comment**

CBD oil has been a game changer for me and my husband.  It helps us sleep much more soundly.

It has come under attack before, with the FDA misleading the public on its safety.  CBD is one of the most well researched non-psychoactive cannabinoids and it has an incredible array of health benefits, with evidence showing that has profound anti-inflammatory and immune modulating effects and can help with painanxietydepressioncertain cancers, and even heart health.

Funny how the ‘the powers that be’ always seem mostly concerned with safe, inexpensive, effective products, but are completely blind, deaf, and dumb to unsafe, expensive, and ineffective ‘vaccines’ and drugs.

I’m sure the goal is to ban this so we are all forced to use something Big Pharma greatly profits from.

SOT For Lyme: Experimental, Expensive, but Full of Potential

https://www.lymedisease.org/sot-lyme-treatment/

SOT therapy for Lyme is experimental, expensive—and full of potential.

Oct. 3, 2025

Part One of a two-part series.

By Maria Marian, ND, MSE

For many people facing chronic infections such as Lyme disease, Epstein–Barr virus (EBV), herpes simplex virus (HSV-1 and HSV-2), or cytomegalovirus (CMV), the journey can be long and frustrating.

Antibiotics, antivirals, herbal therapies, and IV treatments may help initially, yet symptoms often persist or recur. This has led both patients and clinicians to explore innovative therapies that move beyond conventional antimicrobial approaches.

One such emerging option is Supportive Oligonucleotide Therapy (SOT), also referred to as antisense oligonucleotide therapy. Although still considered experimental in the context of Lyme and chronic viral infections, SOT builds upon decades of genetic medicine research and has even reached FDA approval in select infectious and cancer-related applications.

What is SOT?

At its core, SOT is a gene-silencing technique. Scientists design a short synthetic strand of nucleic acid (called an oligonucleotide) that binds to a very specific piece of genetic code inside the pathogen—such as Borrelia burgdorferi (the bacterium that causes Lyme disease) or EBV.

When this oligonucleotide binds, it blocks the pathogen’s ability to produce a protein essential for replication or metabolism. In simple terms, it’s like removing a crucial page from the pathogen’s instruction manual. Without that instruction, the organism can’t replicate efficiently, and its numbers gradually decline.

This strategy falls under the larger field of “antisense therapy.” The term comes from the fact that these therapeutic molecules bind to the “sense” strand of RNA or DNA, neutralizing its ability to produce proteins.

Reference: Crooke ST. Antisense Drug Technology: Principles, Strategies, and Applications. CRC Press; 2008.

How the therapy works

The process of SOT treatment involves several carefully orchestrated steps:

  1. Blood Draw & Testing – A blood sample is taken and analyzed using molecular techniques such as PCR to identify which pathogens are active.
  2. Custom Design – A laboratory designs a patient-specific oligonucleotide tailored to silence a genetic target in that pathogen. Newer approaches like QRE-strain technology (Quasispecies Resistant Engineered strain) aim to account for genetic variations in pathogens, ensuring the oligonucleotide is effective across slightly different strains.
  3. Infusion – Once prepared, the oligonucleotide solution is returned to the clinic and administered as a single intravenous infusion.
  4. Ongoing Action – Unlike antibiotics or antivirals that are metabolized quickly, SOT molecules remain active for months (often up to six months), continuously working “day and night” to suppress pathogen replication.

The Science Behind It

Antisense oligonucleotides are not a new idea. In fact, the first FDA-approved antisense therapy, fomivirsen (Vitravene), was approved in 1998 to treat CMV retinitis in immunocompromised patients【PMID: 9815174】. Since then, several antisense and RNA-based drugs have reached the market for conditions ranging from high cholesterol (mipomersen) to spinal muscular atrophy (nusinersen)【PMID: 29191460】.

In infectious disease specifically:

  • CMV: Fomivirsen demonstrated that gene-silencing therapy can effectively reduce viral activity in humans.
  • Herpesviruses: Preclinical studies have shown that antisense molecules can block HSV and EBV replication in vitro【PMID: 19920191】.
  • Lyme disease: Pilot clinical data suggest that one or two SOT infusions can lead to statistically significant reductions in Borrelia burgdorferi DNA levels detected by PCR. For viral infections, two or three treatments may be needed to achieve measurable decreases.

While more research is essential, these early findings provide a rationale for SOT as a potential adjunctive therapy in chronic infections where other approaches fall short.

Why patients are interested

For individuals struggling with persistent infections, SOT offers several appealing features:

  • Precision targeting: Instead of broadly killing microbes (as antibiotics do), SOT goes after one critical genetic sequence, leaving other microbes untouched.
  • Durability: A single infusion provides months of activity, reducing the need for daily medication.
  • Immune-independent mechanism: Because SOT directly silences genes, it doesn’t rely on the immune system’s strength—a key advantage for patients with immune dysfunction.
  • Potential synergy: Many clinicians use SOT alongside integrative therapies (nutrition, detoxification, antimicrobials) for a more comprehensive approach.

Current limitations

Despite the excitement, it’s important to emphasize what SOT is not at this stage:

  • It is not FDA-approved for Lyme disease, EBV, or HSV. Its only infectious disease approval was for CMV retinitis, and that drug is no longer commercially available.
  • Clinical research in Lyme and chronic viral infections is preliminary, mostly limited to small pilot studies and case reports.
  • Costs can be significant, and insurance rarely covers it.
  • The decline in pathogen burden is gradual, and multiple treatments may be required.

In short: SOT is promising, but it remains an emerging therapy.

Looking ahead with both hope and caution

The field of RNA medicine is growing rapidly, with antisense oligonucleotides, small interfering RNAs (siRNAs), and messenger RNA (mRNA) therapies transforming the landscape of medicine. With continued research, we may see gene-silencing strategies like SOT become mainstream tools in the fight against chronic infections.

For now, patients and clinicians should approach SOT with both hope and caution—hope that it represents a real step forward in treating persistent pathogens, and caution because large, peer-reviewed trials are still needed to fully establish safety, efficacy, and long-term outcomes.

Part two will be published next week.

Maria Marian, ND, MSE, is a naturopathic physician at Jyzen Wellness in Mill Valley, California. In addition to her Doctorate of Naturopathic Medicine, she holds both a Bachelor and Master of Science in Chemical Engineering. She specializes in complex chronic illness, Lyme disease, and integrative approaches to immune dysfunction. Follow her on Instagram: @dr.marian.nd

For more:

According to both Dr. Ross and Dr. Cameron, it’s still too early to confidently recommend SOT for Lyme/MSIDS.

As My Daughter Got Sicker and Sicker, Our Quest For Answers Dragged On. How Did We All Miss Lyme Disease?

https://www.theguardian.com/world/2025/sep/28/as-my-daughter-got-sicker-and-sicker-our-quest-for-answers-dragged-on-how-did-we-all-miss-the-bacteria-taking-over-her-body

As my daughter got sicker and sicker, our quest for answers dragged on. How did we all miss the bacteria taking over her body?

I write about nature, but when Milly got sick with a mystery illness, it never occurred to me that a long-forgotten tick bite could be the cause

There are many reasons to feel guilty. I’m a nature writer who preaches about the importance of wild childhoods, and my daughter has been made chronically ill by one trip to the countryside. I’m a journalist whose job it is to interrogate information and yet I didn’t demand better answers for her from NHS doctors. But the guilt is most painful when I remember a freezing wet day in October 2021.

Milly’s U10s football club were playing the league’s top team. Milly, player of the year the previous season, a whirl of blond energy across the pitch, had lost her enthusiasm for the beautiful game. That morning, she really didn’t want to play: she was tearful and exhausted. There was nothing obviously wrong: no cough, sickness, temperature. Her twin, Esme, was playing but without Milly the team were a player short. I told Milly they needed her. Stoic, she staggered off but couldn’t step on to the pitch. Instead, she curled into a ball of misery and fatigue beside her coach. The rain fell. Her team lost 15-1.

I cringe when I flick through the notebook where I recorded my daughters’ football matches (I was tragically keen). Below most results from the 21/22 season, I’ve written “Milly ill” or, worse, “Milly played ¼” or “Milly played ½”. All the time, cajoled or compelled to lead her “normal” life, Milly was getting sicker and sicker. We had no idea what was wrong. Every morning she looked terrible, dark circles beneath her eyes. She complained of perpetual tiredness, talked of being “disconcentrated” – she later learned to call this “brain fog” – and mentioned strange stabbing pains, mostly in her feet when she walked. Soon, she was too ill to go to school. Lockdown was over but it had become a permanent state for Milly, my wife, Lisa, and me.

What we didn’t know then, and wouldn’t discover until this spring, was that Milly’s body was being invaded by an insidious bacterium, Borrelia burgdorferi, which hides in connective tissue, confounding immune systems, wreaking havoc. Milly had Lyme disease, which takes its name from Old Lyme, a coastal town in Connecticut. This bacterial infection is not contagious but is transmitted by a tick, a tiny, blood-sucking arachnid that hops on to human skin in the countryside, where it is transported by other mammals, particularly deer. There are 476,000, and rising, annual cases in North America alone. Global heating is making ticks, their bacteria – and human illnesses – much more prevalent. (See link for article)

_______________

**Comment**

Another beautiful life side-lined by a bacteria we still know very little about that is infecting people by the millions and chronically affecting the lives untold numbers.

If I had a quarter for every misdiagnosis that was Lyme/MSIDS, I’d be a millionaire.

Will things ever change?

For more:

What’s the Beef With Tylenol?

What’s the Beef With Tylenol?

I’m thankful beyond words I was raised by a woman who would rather die than take a pill.  Seriously, the woman simply ‘dealt’ with whatever malady came her way with a staunch stoicism that Zeno would have been proud of.

Fever?  Put a cold compress on your head.

I truly feel sorry for women today.
Particularly pregnant women posting videos of themselves popping Tylenol simply for political reasons.

While the world normalizes injecting pregnant women with a literal stew of adjuvants, toxins, and contaminants, I was pregnant at a time when injecting a woman with anything would have been viewed as a crime against humanity.  Taking a pain reliever was heavily frowned upon.

Pregnancy’s hard – so suck it up buttercup!

We are now hearing for the first time that Tylenol makers concealed its role in brain inflammation (Autism) cascade for seven years.

http://

Tylenol Link to Autism

Dr. Christina Parks

Sept. 24, 2025

Dr. Christina Parks, PhD in Cellular and Molecular Biology, shares insights on potential links between Tylenol (acetaminophen), vaccines, and autism. She discusses emerging research suggesting that prenatal exposure to acetaminophen may be associated with increased risks of neurodevelopmental disorders, including autism and ADHD. Her message emphasizes the importance of understanding biochemical pathways and the need for caution when using medications during pregnancy.

Parks states that when you combine a vaccine with Tylenol, it is a double whammy completely depleting glutathione, the main ingredient our body uses to suppress inflammation.  Since ‘vaccines’ often cause encephalitis (brain inflammation), the usage of Tylenol, which depletes glutathione, sets the person up to not be able to fend off this inflammation.

Please note the comment after the article:

As a Registered Pharmacist since 1969, I read about hepatotoxicity of Tylenol back in the ’70’s but it was sloughed off as some glitch in a batch or two that came from Japan or something.

Anyway I was in a Hooks drug store in Indianapolis, Indiana in 1972 when the McNeil representative came in and in the course of chatting with him I told him that I had read that Tylenol was toxic to the liver. So I asked him just how toxic it was and he replied:

Every time you take a Tylenol tablet some of your liver cells die…”

From God’s mouth to our ears….

As little as 8 Grams of Tylenol taken in a 24 hour period can be lethal …to put it in context…that is 2 EXTRA Strength Tylenol tablets take every 3 hours around the clock!! The lethal reaction can be delayed for 24 to 48 hours, there is no known way to remove the Tylenol once it is in the body and once the reaction begins there is NO way to stop it!!

BACK THEN it was reported that conservatively around 10,000 Tylenol deaths occurred in the US YEARLY… in 50 years that is 5,000,000 deaths !!!! So while everyone has been heaving and hoeing about thousands of vaccine related deaths and I am sure they exist…. AT LEAST FIVE MILLION AMERICANS HAVE DIED FROM ACCIDENTAL TYLENOL OVERDOSE IN THE LAST HALF DECADE AND NO ONE IS TALKING ABOUT IT….UNTIL NOW! Tylenol SHOULD NEVER BE GIVEN TO INFANTS OR CHILDREN….. IT’S TOXIC TO EVERYONE…~ Dr. Dennis Kinnane OMD LAc RPh

Sadly, the good pharmacist downplays ‘vaccination’ in this drama.  This is a mistake.

As journalist Celia Farber states:

*I hope we can get past the deliberate distortion going around that anybody, RFK Jr. for example, claims Tylenol “causes autism.”

It is present in almost 100% of autism catastrophes, and seems to LOCK IN the reaction the body might otherwise overcome. (Glutathione response.) That would make it a driver of the cascade, or trap—not the originating toxin.

It locks the exits.

Well said.

But the deflection to Tylenol as the sole perp is already revving up hundreds of lawsuits.  To me this is like blaming only one of the three Musketeers.

Go here for a MWD’s more detailed analysis on Tylenol. He wisely states that if a fever is suppressed artificially, the diagnostic signal is lost – like in the case of Lyme and malaria.  Further, suppressing a fever will suppress the body’s ability to suppress illness.

Important quote:

Trials alleging the benefit of NSAIDs are frequently intentionally deceptive and frequently create the illusion of a benefit where none exists. What this means is that many patients ruin their lives with drugs that did almost nothing for them in the first place.—Peter Gøtzsche

Got pain?

Address the root cause – inflammation

For More: